Expand ACIU Menu

ACIU Stock Posts

ACIU stock declines -44.1% in premarket,

Premarket Decliner

ACIU Ac Immune SA10.73+0.27+2.6%

Premarket:6.00-4.73 (-44.1%)

AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimer's Disease

Globe NewswireWed, 30-Jan 1:00 AM

ACIU stock increases 6.1% in premarket,

Premarket Gainer

ACIU Ac Immune SA11.78-0.56-4.5%

Premarket:12.50+0.72 (+6.1%)

AC Immune Announces Price of USD 11.75 for Offerings and Issuance of up to 10 Million Common Shares

Globe NewswireWed, 18-Jul 7:17 PM